Promising genes and variants to reduce chemotherapy adverse effects in acute lymphoblastic leukemia

Almost two decades ago, the sequencing of the human genome and high throughput technologies came to revolutionize the clinical and therapeutic approaches of patients with complex human diseases. In acute lymphoblastic leukemia (ALL), the most frequent childhood malignancy, these technologies have en...

Descripción completa

Detalles Bibliográficos
Autores principales: Bárcenas-López, Diego Alberto, Mendiola-Soto, Diana Karen, Núñez-Enríquez, Juan Carlos, Mejía-Aranguré, Juan Manuel, Hidalgo-Miranda, Alfredo, Jiménez-Morales, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Review article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720095/
https://www.ncbi.nlm.nih.gov/pubmed/33290991
http://dx.doi.org/10.1016/j.tranon.2020.100978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720095/
https://www.ncbi.nlm.nih.gov/pubmed/33290991
http://dx.doi.org/10.1016/j.tranon.2020.100978

Ejemplares similares